important essence as follows: Operating Result Company’s Financial Statement in the Quarter 1/2018 has net loss amount to Baht 21.5 million or Baht 1.22 per share compared to the net loss of Baht 9.4 million
important essence as follows: Operating Result Company’s Financial Statement in the Quarter 2/2018 has net loss amount to Baht 7.4 million or Baht 0.42 per share compared to the net loss of Baht 9.8 million
Baht 939.87 million and new share issuance for capital increase of Baht 55 million. Please be informed accordingly. Yours sincerely, Miss Supamas Isarapakdi Chief Executive Officer DOD Biotech Public
can be summarized the important essence as follows: Operating Result Company’s Financial Statement in the Quarter 3/2018 has net profit amount to Baht 21.99 million or Baht 1.25 per share compared to
announced its interim dividend payment for the operating results of the year 2019 at the rate of 1.48 Baht per share; the payment was scheduled on 8 May 2020. It has also announced the interim dividend
: Operating Result Company’s Financial Statement in the Quarter 2/2020 has net profit amount to Baht 19.20 million or Baht 1.09 per share compared to the net profit of Baht 1.56 million in the Quarter 2/2019
business : 1. Investment in consumer products business 2. Investment in food and beverage business 3. Industrial park development and investment in other businesses Issued and paid-up share capital : Baht
, representing the investment amount of Baht 500,000,000. In this regard, the Company has resolved to authorize the authorization of directors to bind the Company or the Chief Executive Officer or any person
, representing the investment amount of Baht 500,000,000. In this regard, the Company has resolved to authorize the authorization of directors to bind the Company or the Chief Executive Officer or any person
the business transfer date, at a par value of THB 100 per share, or equivalent to 66.00 per cent of SUTG’s issued and paid-up shares (“Entire Business Transfer Transaction”) 2 เลขท่ี 1 อาคาร ทีพี แอนด์